<DOC>
	<DOCNO>NCT01197794</DOCNO>
	<brief_summary>The study ass efficacy , safety tolerability AZD1981 compare non-active compound asthmatic patient .</brief_summary>
	<brief_title>Investigation Efficacy , Safety Tolerability Once Twice Daily Doses AZD1981 Asthmatic Patients</brief_title>
	<detailed_description />
	<criteria>Men woman . Women must surgically sterilized/postmenopausal use double barrier method contraception 6 month history asthma accord ATS definition Prescribed daily dose ICS LABA least 3 month prior Visit 2 Prebronchodilator FEV1 40 85 % predict normal A total ACQ5 score 1.5 Respiratory infection significantly affect asthma Any significant disease disorder may put patient risk influence study result Any clinically relevant abnormal finding A smoking history 10 pack year Intake oral , rectal parenteral glucocorticosteroids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>dose find</keyword>
	<keyword>asthma patient</keyword>
</DOC>